SCHEMBL6406416

SCHEMBL6406416

Cc1ccccc1C(=O)NNC(=O)c1cc2cc(Cl)ccc2[nH]1

nearest known ligand 0.67

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BCAT1 P54687 4/20 0.67
NHERF1 O14745 2/20 0.63
KDM4E B2RXH2 2/20 0.54
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
GUSB P08236 2/20 0.53
F7 P08709 1/20 0.52
F3 P13726 1/20 0.52
HRH4 Q9H3N8 2/20 0.52
HRH3 Q9Y5N1 1/20 0.52
PYGL P06737 2/20 0.52
RXFP1 Q9HBX9 1/20 0.51
MAPT P10636 1/20 0.51
HTT P42858 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
TDP1 Q9NUW8 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6406739 0.93 BCAT1 (0.62) BCAT1NHERF1KDM4EMEN1KMT2A
SCHEMBL6400265 0.88 BCAT1 (0.59) BCAT1NHERF1KDM4EMEN1KMT2A
SCHEMBL6401177 0.87 KDM4E (0.68) BCAT1NHERF1KDM4EMEN1KMT2A
SCHEMBL6399942 0.86 NHERF1 (0.69) BCAT1NHERF1KDM4EMEN1KMT2A
SCHEMBL6400996 0.86 NHERF1 (0.76) BCAT1NHERF1KDM4EMEN1KMT2A
SCHEMBL6399558 0.86 NHERF1 (0.65) BCAT1NHERF1KDM4EMEN1KMT2A
SCHEMBL6401120 0.85 NHERF1 (0.71) BCAT1NHERF1KDM4EMEN1KMT2A
SCHEMBL6399999 0.85 NHERF1 (0.63) BCAT1NHERF1KDM4EMEN1KMT2A
SCHEMBL6402210 0.84 NHERF1 (0.60) BCAT1NHERF1KDM4EMEN1KMT2A
SCHEMBL6400057 0.84 NHERF1 (0.60) BCAT1NHERF1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US claimed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP claimed
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US disclosed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054696-A1 Indole compounds and medicinal use thereof IDO1, GPR119, SLC5A1 BCAT1 854/4885NHERF1 332/4885KDM4E 1617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.